Pharmaceutical Outsourcing Opportunities Post-launch
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition
Pages : 180
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.
A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the core competency of pharmaceutical and biotechnology drug makers.
Detail on Biopharmaceutical Markets
The growing number of biotechnology-driven protein and peptide drugs, antibiotics, chemotherapeutic agents and other compounds administered as sterile injectables, with its concomitant technological requirements, has brought about an increase in the demand for contract sterile manufacturing services. The sheer numbers of biologics in the pipeline are driving drug makers to outsource specialized production rather than build new plants.
As part of its unique coverage of the outsourcing markets for manufacturing and sales, this report includes
CMO and CSO Market Size and Forecasts
Regional Market Breakout (US, Europe, Japan, Latin America, Rest of World)
Overview of CMO/CSO Market and Key Drivers
Key Issues and Trends
Biopharmaceutical Manufacturing
Assessment of Key Companies in the Market
Traditionally, large pharmaceutical companies considered sales and marketing a core competency, and built in-house sales teams and the infrastructure to support promotional activities, launches and general portfolio expansion. However, in recent years, consistent with the "lean-and-mean" business model evolving in the pharmaceutical industry, sales and marketing is shiftingalbeit slowlyfrom a core competency to a prime candidate for outsourcing.
Primary and Secondary Research
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.
For more information please visit :
http://www.aarkstore.com/reports/Pharmaceutical-Outsourcing-Opportunities-Post-Launch-Contract-Manufacturing-and-Contract-Sales-and-Marketing-3rd-Edition-12946.html
From: Aarkstore Enterprise
Contact: Anna
Ph.No.91927282585
Email: winaarkstore@gmail.com
URL:http://www.aarkstore.com/
by: Aarkstore Enterprise
Are you looking to Build an Effective Accounts Receivable Outsourcing Strategy? Outsourcing For Small Start Up Companies Outsourcing to Foreign Countries Why Is Data Entry Outsourcing Required? How Call Center Outsourcing Is Beneficial To Lead Generation Outsource Your Bookkeeping For A Higher Return Why Data Entry Outsourcing Growing Strongly in rising Countries? Is Future Of Data Entry Outsourcing Going to Dead in 2010? Data Entry Outsourcing: How/to Reduce Burden and Expenses Advantages Of Outsourcing Order Processing Needs To A Call Center Structural 3D Modeling is a Perfect Technique – Outsource to get Benefits Why Your Competition Is Outsourcing Their Table Tents What Is Clinical Research Outsourcing?